BUY Gland Pharma Limited — IDBI Capital
byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))6 Oct 2026via IDBI Capital Research Calls Telegram
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·6 Oct · today
Gland Pharma to invest $21 million in US drugmaker, take 60% stake
NewsCnbc-Tv18·1 Oct · 5d ago
3 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·7 Sept · 4w ago
Nothing found in this tip’s window yet.
MACD below its signal line — bearish momentum
Technicals · macd·6 Oct · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Gland Pharma
- BUY — Amit Seth6 Oct 2026 · ~2 weeks · target ₹3,060 · Active
- BUY — ICICI Securities5 Oct 2026 · ~1 year · target ₹3,430 · Active
- BUY — Siddharth Rai Mangala30 Sept 2026 · Same day · target ₹3,070 · SL hit
- BUY — Sumeet Bagadia, Choice Broking29 Sept 2026 · ~2 weeks · target ₹3,220 · SL hit
- BUY — Nirav Chheda, Nirmal Bang Securities29 Sept 2026 · ~2 weeks · target ₹3,200 · SL hit
More from IDBI Capital
- BUY Tata Motors6 Oct 2026 · ~2 weeks · target ₹457 · Active
- BUY Poonawalla Fincorp6 Oct 2026 · ~2 weeks · target ₹481 · Active
- BUY Vijaya Diagnostic Centre6 Oct 2026 · ~2 weeks · target ₹1,580 · Active
- BUY Graphite India6 Oct 2026 · ~2 weeks · target ₹903 · Active
- BUY Engineers India6 Oct 2026 · ~2 weeks · target ₹339 · Active

